You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 3, March 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Hypoxic vs Septic Pulmonary Hypertension

Selective Role of Thromboxane Mediation

Cathy Hammerman, MD; Karl Komar, MD; Hussein Abu-Khudair, MD

Am J Dis Child. 1988;142(3):319-325.


Abstract

• Pulmonary hypertension was generated in 11 newborn piglets, via either infusion of group B β-hemolytic streptococci (n=5) or induction of isocapnic hypoxia (n=6), to study the contributions of thromboxane metabolite thromboxane B2 levels to different types of pulmonary hypertension. After 30 minutes of stable pulmonary hypertension, mean (± SD) pulmonary artery pressure increased similarly from 16±4 to 33±5 mm Hg (hypoxic), and from 14±2 to 34±6 mm Hg (septic). All other measured hemodynamic variables were similar. Despite these hemodynamic similarities, there were significant differences in thromboxane B2 levels. After 60 minutes of pulmonary hypertension, thromboxane B2 levels were 760±253 pg/mL (hypoxic), and 3103±1083 pg/mL (septic). These data demonstrate that, while thromboxane appears to be crucial in mediating septic pulmonary hypertension in the piglet, it is not associated with hypoxic pulmonary hypertension, implying that different types of pulmonary hypertension are probably mediated by different biochemical agents.

(AJDC 1988;142:319-325)



Author Affiliations

From the Department of Pediatrics, Division of Newborn Medicine, University of Chicago.


Footnotes

Accepted for publication Nov 12, 1987.

Presented at the National Society of Pediatric Research Meetings, Anaheim, Calif, April 28, 1987.

Reprint requests to Department of Pediatrics, Box 325, University of Chicago, 5825 Maryland Ave, Chicago, IL 60637 (Dr Hammerman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Thromboxane hypersensitivity in hypoxic pulmonary artery myocytes: altered TP receptor localization and kinetics
Hinton et al.
Am. J. Physiol. Lung Cell. Mol. Physiol. 2007;292:L654-L663.
ABSTRACT | FULL TEXT  

Hypoxia induces hypersensitivity and hyperreactivity to thromboxane receptor agonist in neonatal pulmonary arterial myocytes
Hinton et al.
Am. J. Physiol. Lung Cell. Mol. Physiol. 2006;290:L375-L384.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.